Navin Fluorine International
- Market Cap
- ₹51,687 Cr
- P/E
- 56.75
Key Fundamentals
MidcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 21.00%
- Debt to Equity
- 0.28
- EPS (TTM)
- ₹177.56
- Book Value
- ₹869.91
- Market Cap
- ₹51,687 Cr
- P/E (TTM)
- 56.75
- P/B
- 11.58
- ROE
- 19.80%
- Dividend Yield
- 0.08%
- EBITDA
- ₹1,147 Cr
- 52W High
- ₹10,360.00
- 52W Low
- ₹5,440.00
- Day Range
- ₹10,009.00 – ₹10,308.00
- Volume
- 2,99,889
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| 1,620.00 | 61.46 | 1,64,897 | 14.71 | 1.41% | 23.90% | 31.00% | 16,142 | 2,718 | |
| 4,932.70 | 80.98 | 54,186 | 6.46 | 0.06% | 7.82% | 9.64% | 5,853 | 661 | |
| 10,077.00 | 56.75 | 51,687 | 11.58 | 0.08% | 19.80% | 21.00% | 4,066 | 910 | |
| 1,620.30 | 86.28 | 21,506 | 8.29 | 0.00% | 9.66% | 11.90% | 1,298 | 249 | |
| 1,531.20 | 19.66 | 20,885 | 3.23 | 0.48% | 9.82% | 11.40% | 9,749 | 1,063 | |
| 5,488.50 | 34.93 | 16,828 | 5.74 | 0.20% | 16.60% | 21.50% | 2,604 | 481 | |
| 449.50 | 27.49 | 16,299 | 2.60 | 0.22% | 7.17% | 6.86% | 10,579 | 593 | |
| Median 7 companies | 1,620.30 | 56.75 | 21,506 | 6.46 | 0.20% | 9.82% | 11.90% | 5,853 | 661 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 65
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 26
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 99
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 65
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 98
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 46
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is expected to give good quarter
- Company has delivered good profit growth of 21.6% CAGR over last 5 years
Weaknesses
1- Stock is trading at 11.6 times its book value
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 2 | 4 | 13 |
| Oscillators | Bullish | 2 | 4 | 3 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bullish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 69.23
- Neutral
- MACD (12,26,9)
- 479.82
- Bullish
- SMA (50)
- 8,669.02
- Bullish
- SMA (200)
- 7,490.48
- Bullish
As of
Analyst Rating
20 of 27 analysts rate Buy, 3 Hold, 4 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +17.16% |
|---|---|
| 5Y | +22.96% |
| 3Y | +16.85% |
| 1Y | +41.08% |
| TTM | +45.73% |
Net profit
| 10Y | +22.97% |
|---|---|
| 5Y | +20.81% |
| 3Y | +20.98% |
| 1Y | +129.76% |
| TTM | +104.95% |
Operating cash flow
| 10Y | +27.95% |
|---|---|
| 5Y | +30.41% |
| 3Y | Turned positive |
| 1Y | +56.57% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +15.30 pp |
|---|---|
| 5Y | +6.44 pp |
| 3Y | +6.17 pp |
| 1Y | +9.92 pp |
| TTM | +6.34 pp |
Revenue by year
| Mar 2017 | ₹742 Cr |
|---|---|
| Mar 2018 | ₹913 Cr |
| Mar 2019 | ₹996 Cr |
| Mar 2020 | ₹1,062 Cr |
| Mar 2021 | ₹1,179 Cr |
| Mar 2022 | ₹1,453 Cr |
| Mar 2023 | ₹2,077 Cr |
| Mar 2024 | ₹2,065 Cr |
| Mar 2025 | ₹2,349 Cr |
| Mar 2026 | ₹3,314 Cr |
Net profit by year
| Mar 2017 | ₹137 Cr |
|---|---|
| Mar 2018 | ₹180 Cr |
| Mar 2019 | ₹149 Cr |
| Mar 2020 | ₹409 Cr |
| Mar 2021 | ₹258 Cr |
| Mar 2022 | ₹263 Cr |
| Mar 2023 | ₹375 Cr |
| Mar 2024 | ₹270 Cr |
| Mar 2025 | ₹289 Cr |
| Mar 2026 | ₹664 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Navin Fluorine International trades at ₹10,203 as of 2026-11-19 with a market cap of ₹52,334 crore. The company has delivered strong long-term profit growth of 23% CAGR over 10 years and TTM sales growth of 46%, but the stock commands a premium valuation at 57.46x trailing earnings and 11.73x book value.
- TTM profit growth of 106% signals a sharp acceleration in earnings, well above the 5-year CAGR of 22%
- TTM sales growth of 46% indicates robust revenue momentum, nearly three times the 10-year sales CAGR of 17%
- Consistent long-term compounding with 10-year profit CAGR of 23% and 10-year sales CAGR of 17% reflects durable business quality
- ROCE of 18.66% demonstrates efficient capital deployment and strong returns on invested capital
- Debt-to-equity ratio of just 0.32 indicates a conservatively financed balance sheet with limited leverage risk
- ROE improved to 20% in the last year from a 5-year average of 15%, suggesting improving capital efficiency
- Stock has delivered a 1-year return CAGR of 71% and a 10-year CAGR of 37%, reflecting sustained wealth creation
- The company is expected to deliver a good upcoming quarter, which could sustain the current earnings trajectory
- Trailing P/E of 57.46x is a steep multiple that prices in substantial future growth and leaves little room for earnings disappointment
- Price-to-book of 11.73x is elevated for a chemicals business, implying the market assigns a significant premium over tangible asset value
- Dividend yield of just 0.08% offers virtually no income cushion, making total returns entirely dependent on capital appreciation
- The stock trades at ₹10,203 against a 52-week low of ₹5,440, meaning it has nearly doubled — raising the risk of mean reversion
- 3-year ROE of 14% is below the 10-year average of 17%, suggesting the recent improvement to 20% may not yet be proven as sustainable
- At a 3-year stock CAGR of 42% versus a 3-year profit CAGR of 21%, the stock price has outpaced earnings growth, indicating multiple expansion rather than pure fundamental gains
- The TTM profit surge of 106% creates a high earnings base, making comparable growth in subsequent periods more challenging
- As a specialty chemicals company, earnings can be sensitive to raw material price swings and cyclical demand patterns in end-user industries
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Navin Fluorine is firing on all cylinders — Q2FY27 delivered 81% profit growth and 57% revenue growth, while a $590 million HFO contract extension through 2032 locks in long-term cash flows. The new Surat HFC plant going live adds incremental capacity. No material headwinds surfaced in the period, and with strong earnings momentum plus enhanced revenue visibility, the near-term trend appears firmly positive.
- $590 mn HFO order through 2032 Nov 16
Navin Fluorine secured a major contract extension with Solstice Advanced Materials for HFO supply worth $590 million, extending tenure to December 2032 and significantly bolstering long-term revenue visibility.
- Q2FY27 PAT surges 81% YoY Nov 13
Net profit rose 81.5% YoY to ₹269.24 crore in Q2FY27 while revenue from operations jumped 57% YoY to ₹1,190.74 crore, reflecting broad-based operational strength.
- New HFC plant goes live Nov 12
Commercial operations commenced at the new 15,000 MTPA HFC capacity plant in Surat on Nov 12, 2026, built with a ₹236.50 crore investment, adding a fresh revenue stream.
- ₹8 interim dividend declared Nov 11
Board declared an interim dividend of ₹8 per share with a record date of November 5, 2026. Analyst meetings were scheduled for November 16-17, 2026.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 472 | 500 | 602 | 524 | 519 | 606 | 701 | 725 | 758 | 892 | 938 | 1,045 | 1,191 |
| Expenses | 373 | 424 | 492 | 423 | 411 | 459 | 522 | 519 | 512 | 585 | 617 | 688 | 783 |
| Operating Profit | 98 | 76 | 110 | 100 | 107 | 147 | 179 | 207 | 246 | 308 | 321 | 357 | 407 |
| OPM % | 21% | 15% | 18% | 19% | 21% | 24% | 26% | 29% | 32% | 34% | 34% | 34% | 34% |
| Other Income | 23 | 11.92 | 13 | 10 | 11 | 10 | 12 | 14 | 18 | −5 | 31 | 35 | 15.6 |
| Interest | 20 | 18 | 17 | 16 | 14 | 20 | 28 | 30 | 30 | 28 | 29 | 32 | 28.72 |
| Depreciation | 24 | 25 | 26 | 27 | 28 | 30 | 35 | 35 | 37 | 36 | 41 | 42 | 42.77 |
| Exceptional Items | — | 52.13 | — | — | — | — | — | — | — | — | — | — | — |
| PBT | 77 | 97 | 79 | 68 | 77 | 108 | 127 | 155 | 198 | 238 | 282 | 318 | 352 |
| Tax % | 22% | 20% | 11% | 25% | 23% | 23% | 25% | 24% | 25% | 22% | 25% | 24% | 23% |
| Net Profit | 61 | 78 | 70 | 51 | 59 | 84 | 95 | 117 | 148 | 185 | 213 | 243 | 269 |
| EPS (₹) | 12.22 | 15.74 | 14.19 | 10.32 | 11.86 | 16.86 | 19.15 | 23.62 | 28.96 | 36.18 | 41.48 | 47.43 | 52.47 |
| YoY Sales growth | 13 | −11 | −14 | 7 | 10 | 21 | 16 | 39 | 46 | 47 | 34 | 44 | 57 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 592 | 680 | 742 | 913 | 996 | 1,062 | 1,179 | 1,453 | 2,077 | 2,065 | 2,349 | 3,314 | 4,066 |
| Expenses | 519 | 561 | 582 | 693 | 777 | 794 | 870 | 1,098 | 1,527 | 1,666 | 1,816 | 2,232 | 2,673 |
| Operating Profit | 72 | 118 | 159 | 220 | 219 | 268 | 309 | 356 | 550 | 399 | 534 | 1,082 | 1,393 |
| OPM % | 12% | 17% | 21% | 24% | 22% | 25% | 26% | 24% | 26% | 19% | 23% | 33% | 34% |
| Other Income | 29 | 23 | 55 | 88 | 34 | 29 | 94 | 39.22 | 36 | 107 | 44 | 58 | 77 |
| Interest | 3 | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 28 | 75 | 78 | 118 | 118 |
| Depreciation | 20 | 22 | 30 | 40 | 28 | 37 | 44 | 48 | 63 | 96 | 119 | 149 | 162 |
| PBT | 78 | 116 | 182 | 266 | 224 | 258 | 358 | 344 | 496 | 336 | 380 | 873 | 1,190 |
| Tax % | 26% | 28% | 25% | 32% | 34% | −56% | 31% | 24% | 24% | 19% | 24% | 24% | — |
| Net Profit | 58 | 84 | 137 | 180 | 149 | 409 | 258 | 263 | 375 | 270 | 289 | 664 | 911 |
| EPS (₹) | 11.18 | 17.08 | 27.88 | 36.43 | 30.15 | 82.57 | 52.02 | 53.09 | 75.68 | 54.56 | 58.19 | 129.46 | 177.56 |
| Div. Payout % | 29% | 25% | 23% | 27% | 26% | 13% | 21% | 21% | 16% | 27% | 12% | 7% | — |
| Sales growth | 22 | 15 | 9 | 23 | 9 | 7 | 11 | 23 | 43 | −1 | 14 | 41 | 46 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 578 | 636 | 825 | 974 | 1,063 | 1,402 | 1,624 | 1,834 | 2,175 | 2,373 | 2,616 | 3,964 | 4,452 |
| Borrowings | 61 | 82 | 19 | 13 | 4 | 1 | 25 | 121 | 861 | 1,368 | 1,466 | 1,272 | 1,248 |
| Other Liabilities | 203 | 228 | 324 | 259 | 231 | 215 | 239 | 420 | 484 | 626 | 738 | 1,133 | 1,120 |
| Total Liabilities | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 | 6,831 |
| Fixed Assets | 274 | 375 | 561 | 428 | 430 | 529 | 540 | 556 | 1,646 | 1,875 | 2,736 | 3,324 | 3,397 |
| CWIP | 60 | 20 | 17 | 20 | 39 | 39 | 95 | 742 | 279 | 711 | 355 | 143 | 317 |
| Investments | 171 | 170 | 239 | 428 | 427 | 195 | 99 | 118 | 44 | 495 | 480 | 1,229 | 1,278 |
| Other Assets | 346 | 390 | 360 | 380 | 410 | 866 | 1,163 | 969 | 1,561 | 1,296 | 1,259 | 1,683 | 1,838 |
| Total Assets | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 | 6,831 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1 | 76 | 92 | 169 | 90 | 157 | 237 | 75 | −64 | 750 | 571 | 894 |
| Investing | 3 | −53 | −16 | −136 | −24 | 85 | −237 | −172 | −656 | −1,094 | −511 | −1,235 |
| Financing | −21 | −17 | −67 | −39 | −68 | −81 | −45 | 42 | 658 | 336 | −47 | 344 |
| Net Cash Flow | −17 | 6 | 10 | −6 | −3 | 161 | −45 | −56 | −61 | −8 | 13 | 3 |
| Free Cash Flow | −61 | 58 | −84 | 121 | 29 | 59 | 147 | −501 | −819 | 72 | 4 | 404 |
| CFO/EBITDA | 28 | 87 | 78 | 100 | 74 | 76 | 71 | 43 | 8 | 196 | 122 | 97 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 81 | 68 | 62 | 63 | 75 | 88 | 90 | 99 | 91 | 90 | 83 |
| Inventory Days | 96 | 89 | 136 | 110 | 91 | 127 | 129 | 149 | 197 | 150 | 117 | 121 |
| Days Payable | 113 | 112 | 94 | 92 | 58 | 79 | 77 | 85 | 103 | 122 | 118 | 144 |
| Cash Conversion Cycle | 57 | 57 | 110 | 80 | 96 | 123 | 140 | 154 | 193 | 119 | 89 | 60 |
| Working Capital Days | 39 | 37 | 4 | 43 | 58 | 88 | 113 | 109 | 140 | 45 | 25 | 44 |
| ROCE % | 11% | 17% | 22% | 29% | 21% | 21% | 22% | 19% | 20% | 11% | 11% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Navin Fluorine International insights
70 extracted metrics across FY11–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · May 2026Transcript PPT
- 13 Aug 2026
- 11 Sep 2025
- 9 Oct 2024
- 7 Nov 2023
- 10 Jan 2023
- General announcements 13 Nov 2026
- General announcements 11 Nov 2026
Frequently Asked Questions about Navin Fluorine International
What does Navin Fluorine International Ltd do?
Where is Navin Fluorine International Ltd (NAVINFLUOR) listed?
Which sector does Navin Fluorine International Ltd belong to?
What is the market capitalisation of Navin Fluorine International Ltd?
What is the PE ratio of Navin Fluorine International Ltd?
What is the 52-week high and low of Navin Fluorine International Ltd?
Does Navin Fluorine International Ltd pay dividends?
What is the Return on Equity (ROE) of Navin Fluorine International Ltd?
Company Information
Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services. Its portfolio includes 50+ fluorinated compounds developed over the years.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NAVINFLUOR.md for Navin Fluorine International Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.